Salud financiera de hoja de balance de Advanced Enzyme Technologies
Salud financiera controles de criterios 6/6
Advanced Enzyme Technologies tiene un patrimonio de accionistas total de ₹13.9B y una deuda total de ₹256.9M, lo que sitúa su ratio deuda-patrimonio en 1.8%. Sus activos y pasivos totales son ₹15.5B y ₹1.6B respectivamente. El BAIT de Advanced Enzyme Technologies es de ₹1.7B, por lo que su ratio de cobertura de intereses es de -16.8. Tiene efectivo e inversiones a corto plazo que ascienden a ₹5.1B.
Información clave
1.8%
Ratio deuda-patrimonio
₹256.89m
Deuda
| Ratio de cobertura de intereses | -16.8x |
| Efectivo | ₹5.07b |
| Patrimonio | ₹13.89b |
| Total pasivo | ₹1.60b |
| Activos totales | ₹15.49b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹8.1B) de ADVENZYMES superan a sus pasivos a corto plazo (₹1.0B).
Pasivo a largo plazo: Los activos a corto plazo de ADVENZYMES (₹8.1B) superan a sus pasivos a largo plazo (₹564.4M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ADVENZYMES tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de ADVENZYMES ha pasado de 2.5% a 1.8% en los últimos 5 años.
Cobertura de la deuda: La deuda de ADVENZYMES está bien cubierta por el flujo de caja operativo (553.6%).
Cobertura de intereses: ADVENZYMES gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.